It is critical for leaders in the medtech space to ensure that nonviable medical devices and equipment are destroyed properly, while focusing on long-term sustainability goals.
When a device is implanted in a human body, there is always a distinct reaction of the body’s immune system, often resulting in a thick layer of scar tissue surrounding the implant. With device miniaturization and by providing a ‘biomimetic’ device encapsulation, this body reaction will be reduced.
Whatever the short- and longer-term fallout of COVID-19, organizations will need to come back fighting—with new tools at their disposal and ready to raise their game.
As the saying goes, if it looks too good to be true, it probably is.
Label and packaging artwork processes play an important role in meeting compliance for EU MDR.
U.S. medtech manufacturers must also prepare for the UDI requirements under EU MDR.
Reduce risk and control your label, its design, and the data.
Part three of the design verification series discusses in detail the steps that should be taken during testing.
Prior to design verification of packaged products, consider the following process-related elements.
Mandatory revalidation may not be mandatory when a material change occurs; however, such changes need to be appropriately evaluated. When in doubt, repeat packaging validation. Or, if you believe the scientific evidence/rationale is adequate, then write a robust rationale as to why repeating packaging validation is not required.